These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16333837)

  • 1. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
    Chan EL; Harris RE; Emery KH; Gelfand MJ; Collins MH; Gruppo RA
    Pediatr Blood Cancer; 2007 Apr; 48(4):479-82. PubMed ID: 16333837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
    Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
    J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
    Twist CJ; Naranjo A; Schmidt ML; Tenney SC; Cohn SL; Meany HJ; Mattei P; Adkins ES; Shimada H; London WB; Park JR; Matthay KK; Maris JM
    J Clin Oncol; 2019 Jan; 37(2):115-124. PubMed ID: 30444686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma involvement of the falx cerebri.
    Quackenbush KE; Luna-Fineman S; Magee JF; Gundogan M; Golobi M; Irie T; Fernandez CV
    Pediatr Blood Cancer; 2009 Dec; 53(7):1337-9. PubMed ID: 19821537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
    Kaneko M; Tsuchida Y; Mugishima H; Ohnuma N; Yamamoto K; Kawa K; Iwafuchi M; Sawada T; Suita S
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):613-21. PubMed ID: 12439032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
    Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
    Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
    Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral adrenal cystic neuroblastoma with hepatic and splenic involvement in a newborn.
    Köksal Y; Varan A; Kale G; Tanyel FC; Büyükpamukçu M
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):670-1. PubMed ID: 16344674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique management of stage 4S neuroblastoma complicated by massive hepatomegaly: case report and review of the literature.
    Roberts S; Creamer K; Shoupe B; Flores Y; Robie D
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):142-4. PubMed ID: 11990702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic shock due to spontaneous rupture of adrenal neuroblastoma in an infant: a rare case and review of the literature.
    Honda S; Miyagi H; Minato M; Kubota KC; Okada T
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):635-7. PubMed ID: 23018564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
    Bomken S; Davies B; Chong L; Cole M; Wood KM; McDermott M; Tweddle DA
    Pediatr Hematol Oncol; 2011 Mar; 28(2):106-14. PubMed ID: 21214410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
    Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
    Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
    J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
    Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
    J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage 4S Neuroblastoma: A Report of Two Cases Presenting with Extremes of Biological Behavior.
    Mubarak M; Singal AK; Gawdi A
    Gulf J Oncolog; 2019 May; 1(30):81-84. PubMed ID: 31242987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
    Kushner BH; Kramer K; Modak S; Akhurst TJ; Cheung NK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1340-2. PubMed ID: 19711437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful liver transplantation in an infant with stage 4S(M) neuroblastoma.
    Steele M; Jones NL; Ng V; Kamath B; Avitzur Y; Chami R; Cutz E; Fecteau A; Baruchel S
    Pediatr Blood Cancer; 2013 Mar; 60(3):515-7. PubMed ID: 23152322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule.
    Bishop MW; Yin H; Shimada H; Towbin AJ; Miethke A; Weiss B
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e31-5. PubMed ID: 23528904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
    Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
    J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.